Arbor Biotechnologies
Devyn Smith is the CEO at Arbor Biotechnologies. He was formerly a Treasurer at the Alliance for Regenerative Medicine.
Devyn earned his PhD in Genetics from Harvard Medical School.
Arbor Biotechnologies
2 followers
Arbor Biotechnologies is an early stage life sciences company pushing the boundaries of biodiscovery. Arbor’s platform employs a diverse set of technologies and techniques – including artificial intelligence, genome sequencing, gene synthesis and high-throughput screening – for accelerating the discovery of proteins for improving human health and sustainability.